The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
15 06 2022
Historique:
received: 22 06 2021
revised: 06 12 2021
accepted: 11 01 2022
pubmed: 13 2 2022
medline: 8 7 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

In the third report of the European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery, outcomes of patients receiving mechanical circulatory support are reviewed in relation to implant era. Procedures in adult patients (January 2011-June 2020) were included. Patients from centres with <60% follow-ups completed were excluded. Outcomes were stratified into 3 eras (2011-2013, 2014-2017 and 2018-2020). Adverse event rates (AERs) were calculated and stratified into early phase (<3 months) and late phase (>3 months). Risk factors for death were explored using univariable Cox regression with a stepwise time-varying hazard ratio (<3 vs >3 months). In total, 4834 procedures in 4486 individual patients (72 hospitals) were included, with a median follow-up of 1.1 (interquartile range: 0.3-2.6) years. The annual number of implants (range: 346-600) did not significantly change (P = 0.41). Both Interagency Registry for Mechanically Assisted Circulatory Support class (classes 4-7: 23, 25 and 33%; P < 0.001) and in-hospital deaths (18.5, 17.2 and 11.2; P < 0.001) decreased significantly between eras. Overall, mortality, transplants and the probability of weaning were 55, 25 and 2% at 5 years after the implant, respectively. Major infections were mainly noted early after the implant occurred (AER<3 months: 1.44 vs AER>3 months: 0.45). Bilirubin and creatinine levels were significant risk factors in the early phase but not in the late phase after the implant. In its 10 years of existence, EUROMACS has become a point of reference enabling benchmarking and outcome monitoring. Patient characteristics and outcomes changed between implant eras. In addition, both occurrence of outcomes and risk factor weights are time dependent.

Identifiants

pubmed: 35150247
pii: 6527516
doi: 10.1093/ejcts/ezac032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Theo M M H de By (TMMH)

EUROMACS, EACTS House, Windsor, UK.

Felix Schoenrath (F)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.

Kevin M Veen (KM)

Thorax Center, Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands.

Paul Mohacsi (P)

HerzZentrum Hirslanden, Zürich, Switzerland.

Julia Stein (J)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.

Khalid M M Alkhamees (KMM)

Prince Sultan Cardiac Center Al Hassa, Saudi Arabia.

Kyriakos Anastasiadis (K)

Cardiothoracic Dept, AHEPA University Hospital, Aristotle University, Thessaloniki, Greece.

Alexander Berhnardt (A)

Center for Cardiovascular Surgery and Transplantation Surgery Brno, Brno, Czech Republic.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, University Hospital Freiburg, Freiburg, Germany.
Medical Faculty of the Albert-Ludwigs-University, Freiburg, Germany.

Kadir Caliskan (K)

Thorax Center, Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands.

David Reineke (D)

University Hospital Bern, Bern, Switzerland.

Kevin Damman (K)

Universitair Medisch Centrum Groningen, Groningen, Netherlands.

Arnt Fiane (A)

Rikshospitalet, Oslo, Norway.

Angeliki Gkouziouta (A)

Onassis Cardiac Surgery Center, Athens, Greece.

Can Gollmann-Tepeköylü (C)

Universitätskliniken Innsbruck, Innsbruck, Austria.

Finn Gustafsson (F)

Rigshospitalet, Copenhagen, Denmark.

Michal Hulman (M)

Klinika Kardiochirurgie NUSCH, Bratislava, Slovakia.

Attilio Iacovoni (A)

Ospedale Papa Giovanni XIII, Bergamo, Italy.

Antonio Loforte (A)

San Orsola Hospital, Bologna, Italy.

Bela Merkely (B)

Heart Center of the Semmelweis University, Budapest, Hungary.

Francesco Musumeci (F)

Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.

Petr Němec (P)

Center for Cardiovascular Surgery and Transplantation Surgery Brno, Brno, Czech Republic.

Ivan Netuka (I)

Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.

Mustafa Özbaran (M)

Ege University Hospital, Izmir, Turkey.

Evgenij Potapov (E)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.

Yuri Pya (Y)

National Research Cardiac Surgery Center, Astana, Kazakhstan.

Gregorio Rábago (G)

Clinica Universidad de Navarra, Pamplona, Spain.

Faiz Ramjankhan (F)

Utrecht University Medical Center, Utrecht, Netherlands.

Hermann Reichenspurner (H)

Universitäres Herzzentrum Hamburg, Hamburg, Germany.

Diyar Saeed (D)

Herzzentrum Leipzig, Leipzig, Germany.

Elena Sandoval (E)

ESPAMACS, Sociedad Española de Cirugía Cardiovascular y Endovascular (SECCE), Madrid, Spain.

Bernard Stockman (B)

Onze Lieve Vrouwenziekenhuis, Aalst, Belgium.

Marc Vanderheyden (M)

Onze Lieve Vrouwenziekenhuis, Aalst, Belgium.

Laurens Tops (L)

Leiden University Medical Center, Leiden, Netherlands.

Thorsten Wahlers (T)

Universitätsklinikum Köln AöR, Köln, Germany.

Michael Zembala (M)

Silesian Center for Heart Diseases, Zabrze, Poland.

Daniel Zimpfer (D)

Vienna Medical University, Vienna, Austria.

Thierry Carrel (T)

University Hospital Zürich, Zürich, Switzerland.

Jan Gummert (J)

Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany.

Bart Meyns (B)

Katholieke Universiteit Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH